Naloxone and epinephrine are equally effective for cardiopulmonary resuscitation in a rat asphyxia model

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 9, 2006, Pages 1125-1130

  Chen, M H ^a   Xie, L ^a   Liu, T W ^a   Song, F Q ^a   He, T ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Animal; Asphyxia; Cardiac arrest; Cardiopulmonary resuscitation; Epinephrine; Naloxone

Indexed keywords

ADRENALIN; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPHYXIA; BREATHING PATTERN; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; FEMALE; HEART ARREST; HEART RATE; HEART RHYTHM; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; TREATMENT OUTCOME;

ANIMALS; ASPHYXIA; BLOOD PRESSURE; CARDIOPULMONARY RESUSCITATION; ELECTROCARDIOGRAPHY; EPINEPHRINE; FEMALE; HEART ARREST; HEART RATE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL; VASOCONSTRICTOR AGENTS;

EID: 33748924315     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01141.x     Document Type: Article

References (33)

1. Niemann JT, Haynes KS, Garner D, Rennie CJ 3rd, Jagels G, Stormo O. Postcountershock pulseless rhythms: response to CPR, artificial cardiac pacing, and adrenergic agonists. Ann Emerg Med 1986; 15 (2): 112-20.
2. Tang W, Weil MH, Gazmuri RJ, Sun S, Duggal C, Bisera J. Pulmonary ventilation/perfusion defects induced by epinephrine during CPR. Circulation 1991; 84 (5): 2101-7.
3. Johansson J, Gedeborg R, Rubertsson S. Vasopressin versus continuous adrenaline during experimental cardiopulmonary resuscitation. Resuscitation 2004; 62 (1): 61-9.
4. Sumann G, Krismer AC, Wenzel V, et al. Cardiopulmonary resuscitation after near drowning and hypothermia: restoration of spontaneous circulation after vasopressin. Acta Anaesthesiol Scand 2003; 47 (3): 363-5.
5. Schwarz B, Mair P, Wagner-Berger H, et al. Neither vasopressin nor amiodarone improve CPR outcome in an animal model of hypothermic cardiac arrest. Acta Anaesthesiol Scand 2003; 47 (9): 1114-8.
6. Pasero C, McCaffery M. Reversing respiratory depression with naloxone. Am J Nurs 2000; 100 (2): 26.
7. Lewanowitsch T., Irvine RJ. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur J Pharmacol 2002; 445 (1-2): 61-7.
8. Haglind E. Effects of continuous naloxone infusion in intestinal ischemia shock in the rat. Circ Shock 1992; 38 (3): 195-201.
9. Duarte RR, Ali MM, Sayegh NY, Nayak P, Grace BW. Effects of naloxone infusion in patients with septic shock and renal failure: a limited experience. Am J Nephrol 1992; 12 (6): 431-6.
10. Nash PL. Naloxone and its use in neonatal septic shock. Neonatal Netw 1990; 8 (6): 29-34.
11. Schumann LL, Remington MA. The use of naloxone in treating endotoxic shock. Crit Care Nurse 1990; 10 (2): 63-73.
12. Ebmeyer U, Keilhoff G, Wolf G, Rose W. Strain specific differences in a cardio-pulmonary resuscitation rat model. Resuscitation 2002; 53 (2): 189-200.
13. Berlot G, Gullo A, Romano E, Rinaldi A. Naloxone in cardiorespiratory arrest. Anaesthesia 1985; 40 (8): 819.
14. Espinoza M, Riquelme R, Germain AM, Tevah J, Parer JT, Llanos AJ. Role of endogenous opioids in the cardiovascular responses to asphyxia in fetal sheep. Am J Physiol 1989; 256 (5 Part 2): R1063-8.
15. Myer EC, Morris DL, Adams ML, Brase DA, Dewey WL. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. J Pediatr 1987; 111 (5): 660-6.
16. Ruth V, Pohjavuori M, Rovamo L, Salminen K, Laatikainen T. Plasma beta-endorphin in perinatal asphyxia and respiratory difficulties in newborn infants. Pediatr Res 1986; 20 (6): 577-80.
17. Sankaran K, Hindmarsh KW, Wallace SM, McKay RJ, O'Donnell M. Cerebrospinal fluid and plasma beta-endorphin concentrations in prolonged infant apnea (near-miss sudden infant death syndrome). Dev Pharmacol Ther 1986; 9 (4): 224-30.
18. Mannelli M, Maggi M, De Feo ML, et al. Naloxone administration releases catecholamines. N Engl J Med 1983; 308 (11): 654-5.
19. McIntosh TK, Palter M, Grasberger R, Vezina R, Yeston NS, Egdahl RH. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release. Circ Shock 1985; 17 (4): 313-25.
20. Kienbaum P, Scherbaum N, Thurauf N, Michel MC, Gastpar M, Peters J. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns. Crit Care Med 2000; 28 (4): 969-76.
21. Chang AP, Dillard M, Dixon WR. Effect of naloxone on blood pressure responses and plasma catecholamine levels following clonidine injection in conscious, unrestrained rats. J Cardiovasc Pharmacol 1989; 13 (2): 277-82.
22. Freye E, Hartung E. Naloxone induces excitation of the cardiovascular system and a rise in myocardial oxygen consumption in fentanyl and meperidine-anesthetized dogs. Acta Anaesthesiol Belg 1982; 33 (2): 89-97.
23. Padbury JF, Agata Y, Polk DH, Wang DL, Callegari CC. Neonatal adaptation: naloxone increases the catecholamine surge at birth. Pediatr Res 1987; 21 (6): 590-3.
24. Kienbaum P, Heuter T, Michel MC, Scherbaum N, Gastpar M, Peters J. Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine. Anesthesiology 2002; 96 (2): 346-51.
25. Weil MH, Tang W. Cardiopulmonary resuscitation: a promise as yet largely unfulfilled. Dis Mon 1997; 43 (7): 429-501.
26. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92 (10): 3089-93.
27. Hung CF, Wu MH, Tsai CH, Chu SH, Chi JF, Su MJ. Electrophysiological mechanisms for the antiarrhythmic activities of naloxone on cardiac tissues. Life Sci 1998; 63 (14): 1205-19.
28. Lin CJ, Chen YT, Kuo JS, Lee AY. Antiarrhythmic action of naloxone. Suppression of picrotoxin-induced cardiac arrhythmias in the rat. Jpn Heart J 1992; 33 (3): 365-72.
29. Parker JL, Keller RS, Behm LL, Adams HR. Left ventricular dysfunction in early E. coli endotoxemia: effects of naloxone. Am J Physiol 1990; 259 (2 Part 2): H504-11.
30. Lee AY, Zhan CY, Wong TM. Effects of beta-endorphin on the contraction and electrical activity of the isolated perfused rat heart. Int J Pept Protein Res 1984; 24 (5): 525-8.
31. Gervais HW, Eberle B, Hennes HJ, et al. High dose naloxone does not improve cerebral or myocardial blood flow during cardiopulmonary resuscitation in pigs. Resuscitation 1997; 34 (3): 255-61.
32. Foley PJ, Tacker WA, Voorhees WD, Ralston SH, Elchisak MA. Effects of naloxone on the adrenomedullary response during and after cardiopulmonary resuscitation in dogs. Am J Emerg Med 1987; 5 (5): 357-61.
33. Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med 1996; 3 (7): 660-7.